Haematology
- DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)
- MANUFACTURER: Alnylam Pharmaceuticals
- USAGE: Subcutaneous
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
- Pharmaceuticals and Medical Devices Agency (PMDA)
Givlaari, with the generic name givosiran, is a prescription medication used for the treatment of acute hepatic porphyria (AHP) in adults.
Read more